Perbedaan Harga & Kinerja Asuransi Multi Artha Guna Tbk (AMAG) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga
Pergerakan harga dalam 24 jam terakhir
Statistik utama
Statistik utama
Perbedaan Asuransi Multi Artha Guna Tbk dan Tempo Scan Pacific Tbk.: Asuransi Multi Artha Guna Tbk diperdagangkan di Rp390 (kapitalisasi pasar 1,95 T, volume 24 jam 34,6 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.470 (kapitalisasi pasar 11,23 T, volume 24 jam 699,1 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 5,8× kapitalisasi pasar Asuransi Multi Artha Guna Tbk, dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (699,1 rb vs 34,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| AMAG | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 1,95 T | 11,23 T |
Volume | 34,6 rb | 699,1 rb |
Lot | 346 | 6,99 rb |
Perputaran | 13,4 jt | 1,75 M |
Harga Rata-rata | 387,42 | 2.496,22 |
Nilai Transaksi | 13,4 jt | 1,75 M |
Harga Ekuilibrium Indikatif | 390 | 2.470 |
Volume Ekuilibrium Indikatif | 300 | 90 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Asuransi Multi Artha Guna Tbk
PT Asuransi Multi Artha Guna Tbk (the company) was established at Nov 14, 1980 in Surabaya and at Sept 5, 1997 was moved to Jakarta. The Company's articles of association has been amended from time to time, the latest amendment regarding the change in the Company's status from private company to public company.
Selengkapnya di halaman AMAG →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
